European Commission for the Control of FMD EuFMD Rome All about Foot-and-Mouth Disease! The European Commission for the Control of Foot-and-Mouth Disease (EuFMD), based in FAO HQ, Rome, Italy. European Commission for the Control of FMD’s tracks L. Comtet - Proven performances for FMDV NSP antibody detection with ID Screen® by European Commission for the Control of FMD published on 2020-12-16T14:11:12Z L. Comtet - A new pan FMDV DAS antigen ELISA using multi-serotype-reactive monoclonal by European Commission for the Control of FMD published on 2020-12-16T14:08:23Z L. Comtet - A pan-serotype solid phase blocking ELISA prototype by European Commission for the Control of FMD published on 2020-12-16T13:39:41Z L.Comtet-Ready-to-use solid phase blocking Elisa kits for detection of specific antibodies to FMDV by European Commission for the Control of FMD published on 2020-12-16T12:34:48Z F. Reviriego - Improving business continuity in the EU - the regulatory and policy challenges by European Commission for the Control of FMD published on 2020-12-14T15:35:46Z C. Alvarez - FMD serological blocking ELISA based on VHH for post-vaccination monitoring by European Commission for the Control of FMD published on 2020-12-14T15:09:31Z A. Murray - Continuity of Business during TADs, Lessons from California’s Secure Food Supply Program by European Commission for the Control of FMD published on 2020-12-14T14:17:57Z J. Vaarten - Tackling FAST-diseases through a Public-Private-Partnership by European Commission for the Control of FMD published on 2020-11-25T12:48:19Z A. Meyer, C. Faverjon - Compartmentalisation as a tool for improved resilience by European Commission for the Control of FMD published on 2020-11-25T12:45:59Z G. Savioli Et Al. - A methodology to estimate indirect costs by European Commission for the Control of FMD published on 2020-12-03T10:23:38Z
L. Comtet - Proven performances for FMDV NSP antibody detection with ID Screen® by European Commission for the Control of FMD published on 2020-12-16T14:11:12Z
L. Comtet - A new pan FMDV DAS antigen ELISA using multi-serotype-reactive monoclonal by European Commission for the Control of FMD published on 2020-12-16T14:08:23Z
L. Comtet - A pan-serotype solid phase blocking ELISA prototype by European Commission for the Control of FMD published on 2020-12-16T13:39:41Z
L.Comtet-Ready-to-use solid phase blocking Elisa kits for detection of specific antibodies to FMDV by European Commission for the Control of FMD published on 2020-12-16T12:34:48Z
F. Reviriego - Improving business continuity in the EU - the regulatory and policy challenges by European Commission for the Control of FMD published on 2020-12-14T15:35:46Z
C. Alvarez - FMD serological blocking ELISA based on VHH for post-vaccination monitoring by European Commission for the Control of FMD published on 2020-12-14T15:09:31Z
A. Murray - Continuity of Business during TADs, Lessons from California’s Secure Food Supply Program by European Commission for the Control of FMD published on 2020-12-14T14:17:57Z
J. Vaarten - Tackling FAST-diseases through a Public-Private-Partnership by European Commission for the Control of FMD published on 2020-11-25T12:48:19Z
A. Meyer, C. Faverjon - Compartmentalisation as a tool for improved resilience by European Commission for the Control of FMD published on 2020-11-25T12:45:59Z
G. Savioli Et Al. - A methodology to estimate indirect costs by European Commission for the Control of FMD published on 2020-12-03T10:23:38Z
